| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,255,000 | 2,170,000 | 2,338,000 | 2,251,000 | | Cost of Revenue | 1,551,000 | 1,587,000 | 3,115,000 | 1,032,000 | | | Gross Profit | 704,000 | 583,000 | (777,000) | 1,219,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 80,000 | 75,000 | (1,382,000) | 832,000 | | Non Recurring | (3,000) | (18,000) | (5,000) | 14,000 | | Others | 232,000 | 224,000 | 235,000 | 216,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 395,000 | 302,000 | 375,000 | 157,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 13,000 | 17,000 | 17,000 | 13,000 | | Earnings Before Interest And Taxes | 408,000 | 319,000 | 392,000 | 170,000 | | Interest Expense | 132,000 | 132,000 | 125,000 | 122,000 | | Income Before Tax | 276,000 | 187,000 | 267,000 | 48,000 | | Income Tax Expense | 97,000 | 57,000 | 97,000 | 18,000 | | Minority Interest | (1,000) | (1,000) | (1,000) | (2,000) | | | | Net Income From Continuing Ops | 178,000 | 129,000 | 169,000 | 28,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 8,000 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 178,000 | 129,000 | 177,000 | 28,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $178,000 | $129,000 | $177,000 | $28,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
